These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30635947)

  • 1. Review: PrP 106-126 - 25 years after.
    Forloni G; Chiesa R; Bugiani O; Salmona M; Tagliavini F
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):430-440. PubMed ID: 30635947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
    Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
    Bergström AL; Chabry J; Bastholm L; Heegaard PM
    Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
    J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
    Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
    Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
    Li B
    Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
    Brown DR
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.
    Forloni G; Bugiani O; Tagliavini F; Salmona M
    Mol Chem Neuropathol; 1996; 28(1-3):163-71. PubMed ID: 8871955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Apigenin and Nepetin in the Assembly Behavior and Cytotoxicity of Prion Neuropeptide PrP106-126.
    Huo Y; Zhao C; Wang Y; Wang S; Mu T; Du W
    ACS Chem Neurosci; 2024 Jan; 15(2):245-257. PubMed ID: 38133816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein amyloidosis.
    Ghetti B; Piccardo P; Frangione B; Bugiani O; Giaccone G; Young K; Prelli F; Farlow MR; Dlouhy SR; Tagliavini F
    Brain Pathol; 1996 Apr; 6(2):127-45. PubMed ID: 8737929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmissibility of Gerstmann-Sträussler-Scheinker syndrome in rodent models: New insights into the molecular underpinnings of prion infectivity.
    Nonno R; Angelo Di Bari M; Agrimi U; Pirisinu L
    Prion; 2016 Nov; 10(6):421-433. PubMed ID: 27892798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Unexposed Secrets of Prion Protein Oligomers.
    Wang G; Wang M; Li C
    J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling.
    Song Z; Yang W; Zhou X; Yang L; Zhao D
    Neuropharmacology; 2017 Sep; 123():332-348. PubMed ID: 28545972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.